Safe Group and SpineUp at NASS 2024:
synergies to accelerate the deployment of solutions
Fleurieux-sur-l’Arbresle – France – October 7, 2024 at 6 p.m. Safe SA (FR001400F1V2 – ALSAF), a specialist in the design, manufacture and marketing of medical devices dedicated to spinal surgery, participated alongside SpineUp in the 39th edition of the North American Spine Society (NASS) which took place from September 25 to 28, 2024 in Chicago.
This international event for training, research and innovation in the field of the spine, was an opportunity for companies to present all of their spinal surgery solutions. A team of experts was on hand to discuss and demonstrate the relevance of cutting-edge technologies that facilitate surgery and improve patient outcomes.
For the first time, Safe and SpineUp have proposed a hybrid offer combining implant ranges based on single-use or conventional ancillaries as is the case for the cervical cage range. This new offer has been very well received by players in the American market, from surgeons to distributors.
A large number of conventional instrument manufacturers are interested in developing single-use instrumentation. It is therefore natural that Safe Medical’s ready-to-use device offering has attracted several American and European players who have shown keen interest, both in terms of production capacity and know-how in the development of single-use instruments.
Many contacts were made, both for the Safe and SpineUp solutions, with distributors and surgeons in the United States but also in Germany, Australia, Vietnam, Japan and even Colombia… So many exchanges and contacts to continue the deployment of these technologies.
Safe will continue to communicate information to the market regarding its business activities.
About Safe Group
Safe group is a French medical technology group bringing together Safe Orthopaedics, a pioneer in ready-to-use technologies for spinal pathologies, and Safe Medical (formerly LCI Medical), a subcontractor of medical devices for orthopedic surgery. The group employs approximately 100 people.
Safe Orthopaedics designs and distributes kits combining sterile implants and single-use instruments, available at any time for the surgeon. These technologies are part of a minimally invasive approach aimed at reducing the risks of contamination and infection, in the interest of the patient and with a positive impact on hospitalization times and costs. Protected by 14 patent families, SteriSpineTM kits are CE-approved and FDA-approved. Safe Orthopaedics has subsidiaries in the United Kingdom, Germany, and the United States.
For more information: www.safeorthopaedics.com
Safe Medical produces implantable medical devices and ready-to-use instruments. It has two production sites in France (Fleurieux-sur-l’Arbresle, 69210) and in Tunisia, offering numerous industrial services: design, industrialization, machining, additive printing, finishing and sterile packaging.
For more information: www.safemedical.fr
Contacts
SAFE GROUP AELYON ADVISORS
investors@safeorthopaedics.com safe@aelyonadvisors.fr
